keyword
https://read.qxmd.com/read/38650478/novel-plga-based-nanoformulation-decreases-doxorubicin-induced-cardiotoxicity
#1
JOURNAL ARTICLE
Nikša Drinković, Maja Beus, Rinea Barbir, Željko Debeljak, Blanka Tariba Lovaković, Nikolina Kalčec, Marija Ćurlin, Ana Bekavac, Dunja Gorup, Ivan Mamić, Dario Mandić, Vedran Micek, Petra Turčić, Nazende Günday-Türeli, Emre Türeli, Ivana Vinković Vrček
Nanotechnology has the potential to provide formulations of antitumor agents with increased selectivity towards cancer tissue thereby decreasing systemic toxicity. This in vivo study evaluated the potential of novel nanoformulation based on poly(lactic- co -glycolic acid) (PLGA) to reduce the cardiotoxic potential of doxorubicin (DOX). In vivo toxicity of PLGADOX was compared with clinically approved non-PEGylated, liposomal nanoformulation of DOX (LipoDOX) and conventional DOX form (ConvDOX). The study was performed using Wistar Han rats of both sexes that were treated intravenously for 28 days with 5 doses of tested substances at intervals of 5 days...
April 23, 2024: Nanoscale
https://read.qxmd.com/read/38647131/metabolic-characterization-of-sphere-derived-prostate-cancer-stem-cells-reveals-aberrant-urea-cycle-in-stemness-maintenance
#2
JOURNAL ARTICLE
Yuanyuan Luo, Jiachuan Yu, Zhikun Lin, Xiaolin Wang, Jinhui Zhao, Xinyu Liu, Wangshu Qin, Guowang Xu
Alteration of cell metabolism is one of the essential characteristics of tumor growth. Cancer stem cells (CSCs) are the initiating cells of tumorigenesis, proliferation, recurrence, and other processes, and play an important role in therapeutic resistance and metastasis. Thus, identification of the metabolic profiles in prostate cancer stem cells (PCSCs) is critical to understanding prostate cancer progression. Using untargeted metabolomics and lipidomics methods, we show distinct metabolic differences between prostate cancer cells and PCSCs...
April 22, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38640229/gpr1-and-cmklr1-control-lipid-metabolism-to-support-development-of-clear-cell-renal-cell-carcinoma
#3
JOURNAL ARTICLE
Dazhi Wang, Iqbal Mahmud, Vijay S Thakur, Sze Kiat Tan, Daniel G Isom, David B Lombard, Mark L Gonzalgo, Oleksandr N Kryvenko, Philip L Lorenzi, Vanina T Tcheuyap, James Brugarolas, Scott M Welford
Clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, is largely incurable in the metastatic setting. ccRCC is characterized by excessive lipid accumulation that protects cells from stress and promotes tumor growth, suggesting that the underlying regulators of lipid storage could represent potential therapeutic targets. Here, we evaluated the regulatory roles of GPR1 and CMKLR1, two G-protein coupled receptors of the pro-tumorigenic adipokine chemerin that is involved in ccRCC lipid metabolism...
April 19, 2024: Cancer Research
https://read.qxmd.com/read/38622701/the-impact-of-lipidome-on-breast-cancer-a-mendelian-randomization-study
#4
JOURNAL ARTICLE
Yuchen Cao, Meichen Ai, Chunjun Liu
OBJECTIVE: This study aims to investigate the association between specific lipidomes and the risk of breast cancer (BC) using the Two-Sample Mendelian Randomization (TSMR) approach and Bayesian Model Averaging Mendelian Randomization (BMA-MR) method. METHOD: The study analyzed data from large-scale GWAS datasets of 179 lipidomes to assess the relationship between lipidomes and BC risk across different molecular subtypes. TSMR was employed to explore causal relationships, while the BMA-MR method was carried out to validate the results...
April 15, 2024: Lipids in Health and Disease
https://read.qxmd.com/read/38621425/tanshinone-iia-acts-as-a-regulator-of-lipogenesis-to-overcome-osimertinib-acquired-resistance-in-lung-cancer
#5
JOURNAL ARTICLE
Lin Cao, Zhiyan Qin, Ting Yu, Xupeng Bai, Shiqin Jiang, Daifei Wang, Fangqing Ning, Min Huang, Jing Jin
Osimertinib is a novel epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), acting as the first-line medicine for advanced EGFR-mutated NSCLC. Recently, the acquired resistance to osimertinib brings great challenges to the advanced treatment. Therefore, it is in urgent need to find effective strategy to overcome osimertinib acquired resistance. Here, we demonstrated that SREBP pathway-driven lipogenesis was a key mediator to promote osimertinib acquired resistance, and firstly found Tanshinone IIA (Tan IIA), a natural pharmacologically active constituent isolated from Salvia miltiorrhiza, could overcome osimertinib-acquired resistance in vitro and in vivo via inhibiting SREBP pathway-mediated lipid lipogenesis by using LC-MS based cellular lipidomics analysis, quantitative real-time PCR (qRT-PCR) analysis, western blotting analysis, flow cytometry, small interfering RNAs transfection, and membrane fluidity assay et al...
April 13, 2024: Biochemical Pharmacology
https://read.qxmd.com/read/38612906/wide-targeted-semi-quantitative-analysis-of-acidic-glycosphingolipids-in-cell-lines-and-urine-to-develop-potential-screening-biomarkers-for-renal-cell-carcinoma
#6
JOURNAL ARTICLE
Masamitsu Maekawa, Tomonori Sato, Chika Kanno, Izumi Sakamoto, Yoshihide Kawasaki, Akihiro Ito, Nariyasu Mano
Glycosphingolipids (GSLs), mainly located in the cell membrane, play various roles in cancer cell function. GSLs have potential as renal cell carcinoma (RCC) biomarkers; however, their analysis in body fluids is challenging because of the complexity of numerous glycans and ceramides. Therefore, we applied wide-targeted lipidomics using liquid chromatography-tandem mass spectrometry (LC-MS/MS) with selected reaction monitoring (SRM) based on theoretical mass to perform a comprehensive measurement of GSLs and evaluate their potency as urinary biomarkers...
April 7, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38604366/waterborne-exposure-to-the-antineoplastic-5-fluorouracil-alters-lipid-composition-in-larval-zebrafish-danio-rerio
#7
JOURNAL ARTICLE
Emma Ivantsova, Evelyn Henry, Isaac Konig, Cole English, Christopher L Souders, Adam D Point, Denina Simmons, Christopher J Martyniuk
Antineoplastic medications are present in aquatic environments, measured at relatively high concentrations in hospital sewage effluent. It is thus important to characterize risk associated with waterborne exposures to anticancer drugs. The drug 5-fluorouracil (5-FU) is used to treat several types of cancers, acting to inhibit cell division and cellular metabolism. The objectives of this study were to determine the effects of 5-FU on developmental endpoints and lipid composition in zebrafish. 5-FU did not negatively affect development nor survival in developing zebrafish at concentrations up to 1000 μg/L...
April 9, 2024: Science of the Total Environment
https://read.qxmd.com/read/38546806/development-of-a-highly-efficient-solubilization-method-for-mass-spectrometric-analysis-of-phospholipids-in-living-single-cells
#8
JOURNAL ARTICLE
Jo Sakata, Aogu Furusho, Eiji Sugiyama, Iwao Sakane, Kenichiro Todoroki, Hajime Mizuno
Phospholipids are vital constituents of the cell membrane and aid in signal transduction. Phospholipid profiles vary distinctively with the cell type. Notably, specific phospholipid molecules are present in significantly higher or lower concentrations in cancer cells versus normal cells. In this study, live single-cell mass spectrometry (MS) was developed for analyzing phospholipids at the single-cell level. This method facilitates rapid molecular analysis of cells under microscopic observation. For nanoelectrospray ionization, phospholipids were extracted from single cells isolated in a glass capillary through a high-efficiency process...
March 28, 2024: Analytical Sciences: the International Journal of the Japan Society for Analytical Chemistry
https://read.qxmd.com/read/38542465/metabolic-profiles-and-blood-biomarkers-to-discriminate-between-benign-thyroid-nodules-and-papillary-carcinoma-based-on-uhplc-qtof-esi-ms-analysis
#9
JOURNAL ARTICLE
Gabriela Maria Berinde, Andreea Iulia Socaciu, Mihai Adrian Socaciu, Gabriel Emil Petre, Carmen Socaciu, Doina Piciu
In this study, serum metabolic profiling of patients diagnosed with papillary thyroid carcinoma (PTC) and benign thyroid pathologies (BT) aimed to identify specific biomarkers and altered pathways when compared with healthy controls (C). The blood was collected after a histological confirmation from PTC (n = 24) and BT patients (n = 31) in parallel with healthy controls (n = 81). The untargeted metabolomics protocol was applied by UHPLC-QTOF-ESI+ -MS analysis and the statistical analysis was performed using the MetaboAnalyst 5...
March 20, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38542461/a-workflow-for-meaningful-interpretation-of-classification-results-from-handheld-ambient-mass-spectrometry-analysis-probes
#10
REVIEW
Alexa Fiorante, Lan Anna Ye, Alessandra Tata, Taira Kiyota, Michael Woolman, Francis Talbot, Yasamine Farahmand, Darah Vlaminck, Lauren Katz, Andrea Massaro, Howard Ginsberg, Ahmed Aman, Arash Zarrine-Afsar
While untargeted analysis of biological tissues with ambient mass spectrometry analysis probes has been widely reported in the literature, there are currently no guidelines to standardize the workflows for the experimental design, creation, and validation of molecular models that are utilized in these methods to perform class predictions. By drawing parallels with hurdles that are faced in the field of food fraud detection with untargeted mass spectrometry, we provide a stepwise workflow for the creation, refinement, evaluation, and assessment of the robustness of molecular models, aimed at meaningful interpretation of mass spectrometry-based tissue classification results...
March 20, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38540154/hacking-the-lipidome-new-ferroptosis-strategies-in-cancer-therapy
#11
REVIEW
Borys Varynskyi, Joel A Schick
The concept of redirecting metabolic pathways in cancer cells for therapeutic purposes has become a prominent theme in recent research. Now, with the advent of ferroptosis, a new chink in the armor has evolved that allows for repurposing of ferroptosis-sensitive lipids in order to trigger cell death. This review presents the historical context of lipidomic and metabolic alterations in cancer cells associated with ferroptosis sensitization. The main proferroptotic genes and pathways are identified as therapeutic targets for increasing susceptibility to ferroptosis...
February 28, 2024: Biomedicines
https://read.qxmd.com/read/38539424/the-lipidomic-signature-of-glioblastoma-a-promising-frontier-in-cancer-research
#12
REVIEW
Nina Yu, Orwa Aboud
Glioblastoma is the most aggressive primary brain malignancy in adults, and has a survival duration of approximately 15 months. First line treatment involves surgical resection, chemotherapy, and radiation, but despite the multi-pronged approach and advances in cancer research, glioblastoma remains devastating with a high mortality rate. Lipidomics is an emerging discipline that studies lipid pathways and characteristics, and is a promising field to understand biochemical mechanisms. In glioblastoma, disrupted lipid homeostasis has been reported in the literature...
March 8, 2024: Cancers
https://read.qxmd.com/read/38535623/a-multiomics-assessment-of-preoperative-exercise-in-pancreatic-cancer-survivors-receiving-neoadjuvant-therapy-a-case-series
#13
JOURNAL ARTICLE
Travis Nemkov, Francesca Cendali, Monika Dzieciatkowska, Daniel Stephenson, Kirk C Hansen, Catherine M Jankowski, Angelo D'Alessandro, Ryan J Marker
To molecularly characterize the impact of exercise on mitigating neoadjuvant treatment (NAT)-induced physical decline in pancreatic ductal adenocarcinoma (PDAC) patients, a multi-omics approach was employed for the analysis of plasma samples before and after a personalized exercise intervention. Consisting of personalized aerobic and resistance exercises, this intervention was associated with significant molecular changes that correlated with improvements in lean mass, appendicular skeletal muscle index (ASMI), and performance in the 400-m walk test (MWT) and sit-to-stand test...
March 20, 2024: Pathophysiology: the Official Journal of the International Society for Pathophysiology
https://read.qxmd.com/read/38535333/matrix-and-surface-assisted-laser-desorption-ionization-mass-spectrometry-methods-for-urological-cancer-biomarker-discovery-metabolomics-and-lipidomics-approaches
#14
REVIEW
Adrian Arendowski
Urinary tract cancers, including those of the bladder, the kidneys, and the prostate, represent over 12% of all cancers, with significant global incidence and mortality rates. The continuous challenge that these cancers present necessitates the development of innovative diagnostic and prognostic methods, such as identifying specific biomarkers indicative of cancer. Biomarkers, which can be genes, proteins, metabolites, or lipids, are vital for various clinical purposes including early detection and prognosis...
March 20, 2024: Metabolites
https://read.qxmd.com/read/38532464/bcaa-metabolism-in-pancreatic-cancer-affects-lipid-balance-by-regulating-fatty-acid-import-into-mitochondria
#15
JOURNAL ARTICLE
Klára Gotvaldová, Jitka Špačková, Jiří Novotný, Kamila Baslarová, Petr Ježek, Lenka Rossmeislová, Jan Gojda, Katarína Smolková
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has been associated with the host dysmetabolism of branched-chain amino acids (BCAAs), however, the implications for the role of BCAA metabolism in PDAC development or progression are not clear. The mitochondrial catabolism of valine, leucine, and isoleucine is a multistep process leading to the production of short-chain R-CoA species. They can be subsequently exported from mitochondria as short-chain carnitines (SC-CARs), utilized in anabolic pathways, or released from the cells...
March 26, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38519939/acylcarnitines-promote-gallbladder-cancer-metastasis-through-lncbcl2l11-thoc5-jnk-axis
#16
JOURNAL ARTICLE
Yang Yang, Huaifeng Li, Ke Liu, Lu Zou, Shanshan Xiang, Yajun Geng, Xuechuan Li, Shimei Qiu, Jiahua Yang, Xuya Cui, Lin Li, Yang Li, Weijian Li, Siyuan Yan, Liguo Liu, Xiangsong Wu, Fatao Liu, Wenguang Wu, Shili Chen, Yingbin Liu
BACKGROUND: The progression of gallbladder cancer (GBC) is accompanied by abnormal fatty acid β-oxidation (FAO) metabolism. Different types of lipids perform various biological functions. This study aimed to determine the role of acyl carnitines in the molecular mechanisms of GBC progression. METHODS: Distribution of lipids in GBC was described by LC-MS-based lipidomics. Cellular localization, expression level and full-length of lncBCL2L11 were detected using fluorescence in situ hybridization (FISH) assays, subcellular fractionation assay and 5' and 3' rapid amplification of the cDNA ends (RACE), respectively...
March 22, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38499619/targeting-glucosylceramide-synthase-induces-antiproliferative-and-proapoptotic-effects-in-osimertinib-resistant-nsclc-cell-models
#17
JOURNAL ARTICLE
Silvia La Monica, Federica Vacondio, Kamal Eltayeb, Alessio Lodola, Francesco Volta, Martina Viglioli, Francesca Ferlenghi, Francesca Galvani, Maricla Galetti, Mara Bonelli, Claudia Fumarola, Andrea Cavazzoni, Lisa Flammini, Michela Verzè, Roberta Minari, Pier Giorgio Petronini, Marcello Tiseo, Marco Mor, Roberta Alfieri
The EGFR tyrosine kinase inhibitor osimertinib has been approved for the first-line treatment of EGFR-mutated Non-Small Cell Lung Cancer (NSCLC) patients. Despite its efficacy, patients develop resistance. Mechanisms of resistance are heterogeneous and not fully understood, and their characterization is essential to find new strategies to overcome resistance. Ceramides are well-known regulators of apoptosis and are converted into glucosylceramides (GlcCer) by glucosylceramide synthase (GCS). A higher content of GlcCers was observed in lung pleural effusions from NSCLC patients and their role in osimertinib-resistance has not been documented...
March 18, 2024: Scientific Reports
https://read.qxmd.com/read/38493722/arenobufagin-modulation-of-pcsk9-mediated-cholesterol-metabolism-induces-tumor-associated-macrophages-polarisation-to-inhibit-hepatocellular-carcinoma-progression
#18
JOURNAL ARTICLE
Yueyue Li, Yang Chen, Cheng Zhao, Yuting Yang, Mei Zhang, Hui Cheng, Qinglin Li, Meng Wang
BACKGROUND: The tumor microenvironment (TME) of hepatocellular carcinoma is heterogeneous enough to be prone to drug resistance and multidrug resistance during treatment, and reprogramming of cholesterol metabolism in TME mediates tumor-associated macrophages (TAMs) polarization, which has an impact on the regulation of malignant tumor progression. Arenobufagin (ARBU) was extracted and isolated from toad venom (purity ≥98 %), which is the main active ingredient of the traditional Chinese medicine Chan'su with good anti-tumor effects...
March 13, 2024: Phytomedicine
https://read.qxmd.com/read/38490211/acetyl-coa-carboxylase-obstructs-cd8-t%C3%A2-cell-lipid-utilization-in-the-tumor-microenvironment
#19
JOURNAL ARTICLE
Elizabeth G Hunt, Katie E Hurst, Brian P Riesenberg, Andrew S Kennedy, Evelyn J Gandy, Alex M Andrews, Coral Del Mar Alicea Pauneto, Lauren E Ball, Emily D Wallace, Peng Gao, Jeremy Meier, John J Serody, Michael F Coleman, Jessica E Thaxton
The solid tumor microenvironment (TME) imprints a compromised metabolic state in tumor-infiltrating T cells (TILs), hallmarked by the inability to maintain effective energy synthesis for antitumor function and survival. T cells in the TME must catabolize lipids via mitochondrial fatty acid oxidation (FAO) to supply energy in nutrient stress, and it is established that T cells enriched in FAO are adept at cancer control. However, endogenous TILs and unmodified cellular therapy products fail to sustain bioenergetics in tumors...
March 11, 2024: Cell Metabolism
https://read.qxmd.com/read/38467839/lipidomics-reveals-new-lipid-based-lung-adenocarcinoma-early-diagnosis-model
#20
JOURNAL ARTICLE
Ting Sun, Junge Chen, Fan Yang, Gang Zhang, Jiahao Chen, Xun Wang, Jing Zhang
Lung adenocarcinoma (LUAD) continues to pose a significant mortality risk with a lack of dependable biomarkers for early noninvasive cancer detection. Here, we find that aberrant lipid metabolism is significantly enriched in lung cancer cells. Further, we identified four signature lipids highly associated with LUAD and developed a lipid signature-based scoring model (LSRscore). Evaluation of LSRscore in a discovery cohort reveals a robust predictive capability for LUAD (AUC: 0.972), a result further validated in an independent cohort (AUC: 0...
March 11, 2024: EMBO Molecular Medicine
keyword
keyword
120855
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.